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ABSTRACT 
Quantum chemical calculations are employed to examine the interactions of hydrolysis 
products of cis-[PtCl2(iPram)(Hpz)] with the purine base site of DNA using guanosine as a 
model reactant. Thermodynamic parameters, electronic structures, bonding characteristics and 
spectroscopic properties of the resulting complexes are investigated in the framework of density 
functional theory (B3LYP functional) along with correlation consistent basis sets. Computed 
results show that these interactions are dominated by electrostatic effects, namely H-bond 
contributions. Another remarkable finding is that the replacement of amine groups by larger 
ones accompanies with a moderate reaction between Pt
II
 and guanosine.  
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1. INTRODUCTION 
Cisplatin or cis-diamminedichloroplatinum(II) (cis-[Pt(Cl)2(NH3)2] or cis-DDP), is a 
widely-used antitumor drug which has been particularly successful in treatment of various fatal 
diseases, including testicular, ovarian, head and neck cancers [1, 2]. Unfortunately, the drug 
presents many limitations, for example, several side effects (such as nausea, ear damage, and 
vomiting) or both intrinsic and acquired resistance [3, 4, 5]. Therefore, for the past decades 
much effort has been devoted to the exploitation of alternative platinum complexes in order to 
limit these drawbacks [6]. 
However, the search for analogous compounds that outperform cisplatin has proved to be 
an extremely difficult task, not only because of the diversity of the compositions, structures and 
properties of replaced ligands, but also due to the lack of quantitative atomic level information 
about the features controlling Pt-DNA interactions. Indeed, thousands of platinum compounds 
have been synthesized so far [2, 7], but only a few new agents such as oxaliplatin, carboplatin 
and nedaplatin have been registered worldwide and entered clinical practice [8]. In this context, 
a thorough understanding of interactions between the Pt and DNA building blocks is thought to 
be helpful in designing cisplatin analogues. 
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Recently, quantum chemical calculations have widely been used and made significant 
contributions to a deeper understanding of the interaction mechanisms between cisplatin and 
DNA. From the early time,  using Hartree-Fock (HF) model in conjunction with the minimal 
basis set STO-3G, Kozelka and co-workers were able to reproduce some structural patterns of 
cis-DDP–base DNA [9, 10]. Other remarkable results on structural aspects of the complexes 
between platinum and biomolecules come from the Carloni group, based on the application of 
the density functional theory (DFT) [11, 12]. 
The hydrolysis of cisplatin and some features of the changes in electronic structure 
including the influence of platination on base pairs, or the proton affinity have also been 
intensively studied at different levels of theory [13, 14, 15, 16, 17]. Recently, a combined 
IRMPD, MS/MS and theoretical study on interactions of cisplatin and base purines has been 
intensively examined with the aim to provide an accurate characterization of the resulting 
complexes [18]. 
In this work, we carry out an examination on the interactions between an asymmetric 
derivative of cisplatin, i.e. cis-[PtCl2(iPram)(Hpz)] (where iPram is isopropylamine and Hpz is 
pyrazole), and DNA base sites using guanosine as a model reactant. The cytotoxicity of the 
complex in several human cell lines was found to be lower than that of cisplatin [19], but further 
information is still not clarified. Although geometric parameters or spectroscopic information 
can be sufficiently collected by experimental techniques, it is more difficult to combine 
structural data with energetic properties using only traditional observations. Advanced quantum 
chemical methods become potential and effective tools to achieve these purposes.  
2. MATERIALS AND METHODS 
All calculations are performed using the Gaussian 09 suite of program [20] in the 
framework of density functional theory [21]. The hybrid B3LYP functional in conjunction with 
the correlation consistent cc-pVTZ-PP and cc-pVTZ basis sets is employed for geometry 
optimization and energetic calculations as well. The basis set with an effective core potential 
(ECP) cc-pVTZ-PP [22] is applied for platinum, while the all electrons cc-pVTZ basis set is 
used for the non-metals. 
The ECP cc-pVTZ-PP basis set already includes relativistic effects that are very crucial in 
treatment of heavy elements such as platinum. Harmonic vibrational frequencies are also 
calculated to confirm the character of optimized geometries as local minima or transition states 
on the potential energy surface, and to estimate the zero-point vibrational energy (ZPE) 
corrections. The natural bond orbital (NBO) charges of atoms are computed using the NBO5.G 
code [23]. We exploit NBO charges for electron population analysis instead of Mulliken charges 
because the former are expected to be more reliable [24]. 
Previous studies confirm that after entering the cell by passive diffusion through the cell 
membrane cisplatin undergoes spontaneous hydrolysis via nucleophilic substitution of chloride 
with water to form cationic complexes [Pt(NH3)2(H2O)Cl]
+ 
and [Pt(NH3)2(H2O)2]
2+
 [25].
 
This 
process is a fundamental step determining the anticancer activity of cisplatin as it leads to 
reactive metabolites that ultimately give rise to DNA adducts [26]. Both complexes can be 
substituted easily by donor ligands such as nitrogen-containing bases of DNA with the loss of 
water, but it is currently unclear whether the monoaqua or diaqua species to be more important 
[27]. Previous studies have shown that interactions of Pt
II
 with guanine prefer to occur at the N7 
position. Hence, current work just pays attention to the examine the binding of cis-
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[PtCl2(iPram)(Hpz)] to guanosine via the N-7 site. The exchange-ligand energies (E
T
) of these 
complexes with guanine are computed based on following process: 
   [PtLL’(H2O)Cl]
+
 + G → [PtLL’(G)Cl]+ + H2O 
As for a convention, a negative value of E
T
 corresponds to a favorable interchange, but the 
selectivity is low. In addition, this parameter can be used to evaluate the relative stability of a 
specific Pt-guanosine complex. 
3. RESULTS AND DICUSSION 
3.1. Interactions of [Pt(iPram)(Hpz)(H2O)Cl]
+ 
with guanosine  
  
Similar to [PtCl2(NH3)2], the [PtCl2(iPram)(Hpz)] has two structural isomers as shown in 
Figure 1. At the level of theory applied in this study, the cis form is predicted to be somewhat 
less stable than the trans counterpart, being separated by about 6.5 kcal/mol.  
In the [PtCl2(iPram)(Hpz)], the distance of Pt – Cl bonds, being about 2.31 Å computed at 
B3LYP/cc-pVTZ(PP) leval, is quite longer than that of Pt – N bonds. Indeed, the bond lengths of 
Pt – NH (Hpz) and Pt – NH2 (iPram) are predicted to be 1.99 and 2.12 Å, respectively. 
Therefore, in ligand-exchange reactions, the anions Cl
–
 are seemingly more willing to be 
removed than the amine groups.   
 
 
 
 
Figure 1. Two structural isomers of [PtCl2(iPram)(Hpz)].  
The possible isomers detected for cation [Pt(iPram)(Hpz)(Go)Cl]
+
, along with their relative 
energies computed at the B3LYP/cc-pVTZ-(PP) + ZPE level, are displayed in Figure 2. The 
result shows that the resulting complexes are stabilized as they can form a hydrogen bond via the 
CO group with either NH2 (iPram) or NH (Hpz) group.   
 
 
 
Pham Vu Nhat 
 
54 
 
Pt(iPram)Hpz(Go)-1; [0.0] 
 
Pt(iPram)Hpz(Go)-2; [0.8] 
 
 
Pt(iPram)Hpz(Go)-3; [6.7] 
 
Pt(iPram)Hpz(Go)-4; [7.8] 
Figure 2. Possible structures obtained for [Pt(iPram)(Hpz)(Go)Cl]
+
 complex. The values                            
(kcal/mol) in square brackets are their relative energies. 
  
As shown in Figure 2, two lowest-energy structures obtained for the cation 
[Pt(iPram)(Hpz)(Go)Cl]
+ 
are Pt(iPram)Hpz(Go)-1 and Pt(iPram)Hpz(Go)-2. These forms are 
stabilized owing to electrostatic interactions either between the NH group on pyrazole (Hpz) or 
the NH2 group on isopropylamine (iPram) and O atom of guanosine. On the contrary, both forms 
Pt(iPram)Hpz(Go)-3 and Pt(iPram)Hpz(Go)-4 become significantly less stable due to lack of a H 
bond as in Pt(iPram)Hpz(G)-1 though both structures are quite similar. These forms are 
evaluated to be around 6.7 – 7.8 kcal/mol higher in energy than the ground state. Thus such a 
gap can be considered as the H-bond energy in the complex [Pt(iPram)(Hpz)(Go)Cl]
+
.  
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Table 1. Exchange-ligand energy (E
T
) and bond lengths Pt–N7; NH O in [Pt(iPram)(Hpz)(G)Cl]+. 
Structure E
T
 (kcal/mol)  ( )  ( ) 
Pt(iPram)Hpz(Go)-1 –43.1 2.05 1.72 
Pt(iPram)Hpz(Go)-2 –42.3 2.04 1.82 
Pt(iPram)Hpz(Go)-3 –36.4 2.06 – 
Pt(iPram)Hpz(Go)-4 –35.3 2.06 – 
Table 1 summarizes computed results obtained for species [Pt(iPram)(Hpz)(Go)Cl]
+
. The 
ligand exchange energy at the B3LYP/cc-pVTZ/cc-pVTZ-PP level for the monoaqua complex 
ranges from –43.1 kcal/mol (Pt(iPram)Hpz(G)-1) to –35.3 kcal/mol (Pt(iPram)Hpz(Go)-4). The 
values can be considered as enthalpy changes of reactions. It follows from the Table 1 that if the 
entropy factor is negligible these reactions would occur spontaneously and be exothermic. In 
addition, the absolute values of the reaction energy (above 35 kcal/mol) are high enough for 
unambiguous conclusions. 
At the same level employed in this study, the ligand exchange energy of cis-
[Pt(NH3)2(H2O)Cl]
+
 with guanosine is computed to be around –46.3 kcal/mol. This value is thus 
more negative than that of the derivative [Pt(iPram)(Hpz)(H2O)Cl]
+
. Hence it can be expected 
that the former is more willing to exchange the water group by means of a base than the latter. In 
other word, the replacement of ammine groups by larger ones such as iPram and Hpz 
accompanies with a somewhat moderate reaction between Pt
II
 and guanosine.  
3.2. Interactions of [Pt(iPram)(Hpz)(H2O)2]
2+ 
with guanosine 
The replacement of two aqua ligands in the cation [Pt(iPram)(Hpz)(H2O)2]
2+
 by guanosine 
molecules gives rise to the complex [Pt(iPram)(Hpz)(Go)2]
2+
 with possible structures plotted in 
Figure 3. It can be seen that all the structures are stabilized due to hydrogen bonds, even with the 
least stable form. In both forms Pt(iPram)Hpz(Go)2-1 and -2, hydrogen bonds are established 
between the hydrogen atom of the Hpz and iPram ligands and the oxygen atom at the C6 
position. Their relative energy at the applied level of theory in this work is insignificant, being 
only around 0.7 kcal/mol. Within the error bar of the computational methods, these forms can be 
regarded to be degenerate and each of them can emerge as the ground state. 
Table 2. Exchane-ligand energy (E
T
) and some geometric parameters in [Pt(iPram)(Hpz)(Go)2]
2+
. 
Structure E
T
 (kcal/mol)  ( )  ( ) 
Pt(iPram)Hpz(Go)2-1 –118 2.06 1.77; 1.88 
Pt(iPram)Hpz(Go)2-2 –117 2.07 1.77; 1.89 
Pt(iPram)Hpz(Go)2-3 –114 2.06 1.77 
Pt(iPram)Hpz(Go)2-4 –112 2.05 1.90 
On the contrary, the Pt(iPram)Hpz(Go)2-3 becomes less stable as only one H-bond via the 
Hpz group is allowed. This conformation is computed to be about 3.5 eV above the most stable 
Pt(iPram)Hpz(Go)2-1, which contains two H-bonds. Similarly, Pt(iPram)Hpz(Go)2-4 is least 
stable because it can form one H-bond via the iPram ligand. As expected, the NH group of 
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pyrazole is a much better hydrogen-bond donor than the NH2 group of iPram. Indeed, the 
stronger interaction is reflected in the distance of the  bond in platinated guanosine 
adducts as shown in Table 2. The  hydrogen bond is computed to be around 1.77  
as compared to the value of 1.89 – 1.89  for . The hydrogen bond is thus 
expected to contribute approximately 6.0 kcal/mol to the bond energy in the complex 
[Pt(iPram)(Hpz)(Go)2]
2+
. 
 
Pt(iPram)HpzAq(Go)-1; [0.0]  
Pt(iPram)HpzAq(Go)-2; [0.7] 
 
Pt(iPram)HpzAq(Go)-3; [3.5] 
 
Pt(iPram)HpzAq(Go)-1; [6.0] 
Figure 3. Possible structures detected for [Pt(iPram)(Hpz)(G)(H2O)]
2+
.                                                       
The values (kcal/mol) in square brackets are their relative energies. 
The ligand exchange energies (E
T
) along with the bond lengths Pt–N7(G) and distances of 
H-bonds XH  O are  summarized in Table 2. The results indicate that if the diaqua complex is 
used, the platination of guanine is more thermodynamically preferable by around 23 kcal/mol. 
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The E
T
 values predicted for the diaqua complex
 
vary from –118 to –112 kcal/mol (Table 2), as 
compared to the values of –43 to –35 kcal/mol calculated for the monoaqua species (Table 1). 
Thus, in terms of thermodynamics, cation [Pt(iPram)(Hpz)(H2O)2]
2+
 is more willing to 
interchange one water ligand with guanosine than the monoaqua complex 
[Pt(iPram)(Hpz)(H2O)Cl]
+
. 
3.3. Changes in geometric parameters and vibrational frequencies 
As illustrated in Table 3, the introduction of NH ⋯ O interaction leads to significant 
changes in bond lengths and vibrational frequencies of the bonding N–H in systems considered. 
Our calculations show that as a consequence of a strong electrostatic interaction, bond lengths of 
N–H and HN–H are increased by 0.02 – 0.03 Å. Such observations are clearly manifested in the 
frequency red-shift of the stretching modes υ(N – H) and υ(HN – H), being around 320 – 477 
cm
–1
 (Table 3). For instance, the N–H and NH–H distances of Hpz and iPram ligands in 
[Pt(iPram)(Hpz)(H2O)Cl]
+
 is computed to be 1,00 and 1,02 Å, respectively, as compared to a 
value of 1,03 Å in Pt(iPram)Hpz(Go)-1 and Pt(iPram)Hpz(Go)-2. For example, in agreement the 
change in bond lengths, the stretching mode  υ(N – H) is significantly red-shifted to 3173 cm–1 
when forming the complex Pt(iPram)Hpz(Go)-1, while these vibrations are predicted to occur at 
3650 cm
–1
 in [Pt(iPram)(Hpz)(H2O)Cl]
+
. 
Forming the hydrogen bond influences not only on X–H bonds but also on the carbonyl 
group of guanine. This phenomenon can be explained by the formation of a hydrogen bond 
weakening the double bond character, and also by the proximity of the platinum ion. At the 
applied level of theory, the stretching mode C=O is computed to be about 1796 cm
-1
 in free 
guanosine. For Pt(iPram)Hpz(G)-1, due to the presence of the hydrogen bond, a significant red-
shift is observed as the mode υ(C=O) now shifts to 1728 cm–1. Although, the experimental IR 
spectra for complexes considered in this study have not been published so far, they are reported 
here as predictions that may allow one to verify the optimal structures when the spectroscopic 
information is available. Figures 5 and 6 are plots of the vibrational signatures for lowest-lying 
states of the monoaqua and diaqua along with [Pt(iPram)(Hpz)(Go)Cl]
+
 and 
[Pt(iPram)(Hpz)(Go)2]
+
 adducts.  
Table 3. The changes in bond lengths ( , ), harmonic frequencies ( , cm
–1
) of X–H                            
bonds when forming H-bonds. 
Complex Bonding   Complex Bonding   
Pt(iPram)Hpz(Go)-1 N–H 0.03 –477 Pt(iPram)HpzAq(Go)-1 HN–H 0.00 –11.0 
Pt(iPram)Hpz(Go)-2 N–H 0.00 –4.00 Pt(iPram)HpzAq(Go)-2 HN–H 0.02 –207 
Pt(iPram)Hpz(Go)-3 N–H 0.02 –350 Pt(iPram)HpzAq(Go)-3 HN–H 0.00 –15.0 
Pt(iPram)Hpz(Go)-4 N–H 0.00 5.00 Pt(iPram)HpzAq(Go)-4 HN–H 0.02 –220 
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Figure 4. Vibrational signatures of [Pt(iPram)(Hpz)(H2O)Cl]
+
 (above) and                                 
[Pt(iPram)(Hpz)(Go)Cl]
+
 (below) in their lowest-lying states. 
 
Figures 4 and 5 show that the IR spectra of both the monoaqua and diaqua complexes can 
be classified into two specific regions, namely the finger-print bands 500 – 1700 cm–1 and the X 
– H stretching bands 3000 – 3700 cm–1. As mentioned above, the vibrational spectra of these 
systems are strongly dependent on the nature of surrounded atoms. We actually observe 
significantly large modifications in band intensities and frequencies of the complexes during the 
interchange water and guanine ligands. The replacement of a water ligand by a guanine not only 
modifies the vibrational features in the finger-print region, but also leads to large red-shifts of X 
– H stretching modes in Hpz and water ligands. 
The spectra of both [Pt(iPram)(Hpz)(H2O)Cl]
+
 and [Pt(iPram)(Hpz)(H2O)2]
2+
 show several 
intense peaks in the range of 3000 – 3700 cm–1. In the computed spectrum of the monoaqua 
complex the most remarkable are the highest-intensity and highest-frequency features at 3631 
and 3793 cm
–1
, respectively. These bands correspond to the symmetric and asymmetric O – H 
stretching modes of the water ligand. The other peak at 3651 cm
–1 
is associated to the N7–H 
(Hpz) stretching. For the diaqua complex, two bands at 3800 and 3720 cm
–1 
are due to the 
symmetric and antisymmetric stretching of OH (water), while the  absorption around 3637 cm
–1
 
is assigned to the N7–H (Hpz) stretching. The stretching modes of NH2 (iPram) also lies in this 
region, being predicted at ~3490 cm
–1
, but they are too weak to observe in the computed spectra. 
It is clearly seen from Figures 4 and 5 that the appearance of the hydrogen bonding 
interaction when the H2O molecule is replaced by the guanosine leads to a significant change in 
the stretching regions. The predicted spectrum of Pt(iPram)Hpz(Go)-1 contains at least four 
distinct peaks in the range above 3000 cm
–1
. The antisymmetric stretching mode of NH2
 
(guanine) is found to vibrate at 3723 cm
–1
. Other main absorptions estimated at 3630, 3575 cm
–1 
correspond to N9–H and N1–H (guanine) stretches. The highest intensity peak observed at 3238 
cm
–1
 belongs to the stretching of N–H (Hpz). When the hydrogen bond is not allowed, this 
vibration is calculated to appear around 3651 cm
–1
. The highest-energy vibration at 3800 cm
–1
 is 
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related to the O–H stretching of water ligand that is not involved in hydrogen bonding. For the 
isomer Pt(iPram)Hpz(Go)2-1, two H-bonds are found between the hydrogen atoms in Hpz, 
iPram groups and the carbonyl group of guanosine. In addition, the stretching region of 
Pt(iPram)Hpz(Go)2-1 appears other particularly strong peaks centered at 3500 – 3600 cm
–1
, 
being associated to symmetric stretches of N–H and HNH groups of guanosine.   
 
Figure 5. Vibrational signatures of [Pt(iPram)(Hpz)(H2O)2]
2+
 (below) and                             
[Pt(iPram)(Hpz)(Go)2]
+
  (above) in their lowest-lying states. 
4. CONCLUSIONS 
In this study, interactions of hydrolysis products of an asymmetric derivative of cisplatin 
with nucleobase guanosine are systematically are investigated by using quantum chemistry 
calculations. Density functional method B3LYP combined with correlation consistent basis  sets 
(cc-cc-pVTZ and pVTZ-PP) is employed to examined thermodynamic parameters, electronic 
structures, bonding characteristics, spectroscopic properties, ... on a variety of chemical systems, 
rather than using traditional experimental techniques. 
Computed results show that the resulting complexes are stabilized due to forming strong 
hydrogen bonds between the H atoms of amine groups and the O6 of guanosine. The structures 
without H-bond are predicted to be around 1.0 – 8.0 kcal/mol higher in energy. Thus interactions 
between the derivative cis-[PtCl2(iPram)(Hpz)] with guanosine are dominated by H-bond 
contributions. 
Another significant finding is that the replacement of ammine groups by larger ligands such 
as iPram, Hpz accompanies with a somewhat moderate reaction between Pt
II
 and guanine. The 
aqua – guanosine ligand exchange energies are computed to be –46 and –43 kcal/mol for cis-
[Pt(NH3)2(H2O)Cl]
+
 and [Pt(iPram)(Hpz)(H2O)Cl]
+ 
respectively. This is consistent with the 
experiment that the cytotoxicity of the complex in several human cell lines was found to be 
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lower than that of cisplatin.  
The presence of XH  O interaction in addition leads to large modifications in bond lengths 
and vibrational frequencies of the X─H bonds. As a results of strong electrostatic effects, bond 
lengths of N–H and HN–H are increased by 0.01 – 0.03 Å, corresponding to significant 
frequency red-shifts of the stretching modes  υ(N – H) and υ(HN – H), being around 320 – 477 
cm
–1
. Even though the experimental IR spectra for systems considered in this study have not 
been published so far, they are reported here as predictions that may allow one to verify the 
optimal structures when the spectroscopic information is available.  
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